Amgen

Amgen Inc. (NASDAQ: AMGN) is one of the world's largest independent biotechnology companies, pioneering breakthrough therapies in oncology, cardiovascular disease, bone health, neuroscience, and inflammation with blockbuster drugs including Enbrel, Prolia, Otezla, Repatha, and the obesity treatment MariTide in its pipeline. Founded in 1980, the company has grown from a startup into a biotech giant with annual revenues exceeding $25 billion, driven by a robust portfolio of biologic medicines a...

Threads